Yet, we still cannot exclude the possibility that kalirin–GEF1 inhibition is involved in programmed cell death in stage 4S NB cells, being insufficient to purge those NB cells that harbour secondary alterations (e.g., MYCN amplification). This evidence concerns the gene ARHGEF1 and neuroblastoma.